Background
Methods
Study design
Blood collection
Plasma and serum preparation and storage
Analysis of plasma and serum proteins
Statistical analysis
Results
Proteomic profiles of serum, plasma, recalcified plasma and heat inactivated plasma
Comparison of serum and plasma
Factor Levels | ||||
---|---|---|---|---|
Factor | Serum | Plasma | Fold Difference | p* |
Factor whose levels were greater in plasma
| ||||
Fibrinogen (microg/mL) | 3.13 ± 7.21 | 4,812 ± 1,780 | 24,500± 20,700 | 2.54E-07 |
OPN (ng/mL) | 1.82 ± 1.18 | 4.12 ± 1.48 | 2.7 ± 1.0 | 5.61E-05 |
Factors whose levels were greater in serum
| ||||
TNFR1 (pg/mL) | 582 ± 139 | 422 ± 103 | 1.39 ± 0.21 | 7.46E-05 |
MIP-1α (pg/mL) | 96.2 ± 22.0 | 56.4 ± 8.8 | 1.71 ± 0.35 | 0.00014 |
ITAC (pg/mL) | 78.4 ± 15.8 | 51.0 ± 7.3 | 1.55 ± 0.27 | 0.00014 |
NAP-2 (microg/mL) | 4.79 ± 7.16 | 0.183 ± 0.321 | 62.48 ± 96.9 | 0.00019 |
Lymphotactin (pg/mL) | 125 ± 104 | 103 ± 96 | 1.30 ± 0.20 | 0.00056 |
MIP-1β (pg/mL) | 98.5 ± 64.0 | 74.3 ± 58.6 | 1.39 ± 0.31 | 0.0012 |
MCP-2 (pg/mL) | 47.1 ± 11.3 | 31.1 ± 10.2 | 1.62 ± 0.50 | 0.0013 |
TIMP-1 (ng/mL) | 106.3 ± 25.167 | 71.8 ± 8.36 | 1.50 ± 0.39 | 0.0016 |
PAI-1 total (pg/mL) | 4,177 ± 3,170 | 929 ± 746 | 9.19 ± 15.21 | 0.0023 |
Eotaxin 2 (pg/mL) | 1,976 ± 1,366 | 988 ± 576 | 1.93 ± 0.84 | 0.0028 |
MIP-3α (pg/mL) | 17.1 ± 7.0 | 11.8 ± 6.3 | 1.53 ± 0.47 | 0.0030 |
Exodus 2 (pg/mL) | 57.3 ± 16.5 | 48.7 ± 10.6 | 1.17 ± 0.15 | 0.0048 |
RANTES (ng/mL) | 22.0 ± 20.2 | 5.77 ± 2.22 | 4.67 ± 5.19 | 0.0051 |
MMP-9 (ng/mL) | 32.1 ± 23.5 | 11.4 ± 4.4 | 3.38 ± 3.24 | 0.0064 |
PDGF-BB (pg/mL) | 214 ± 225 | 32.7 ± 19.8 | 9.97 ± 12.29 | 0.0072 |
ACRP-30 (microg/mL) | 15.52 ± 14.83 | 11.26 ± 11.33 | 1.50 ± 0.57 | 0.0076 |
APO-A1 (microg/mL) | 208.2 ± 38.49 | 173.2 ± 46.95 | 1.25 ± 0.26 | 0.0089 |
MCP-3 (pg/mL) | 4.7 ± 3.9 | 1.5 ± 2.5 | 3.10 ± 0.41 | 0.0096 |
Comparison of factor levels in recalcified plasma, regular plasma and serum
Factor Levels | ||||
---|---|---|---|---|
Factor | Plasma | Recalified Plasma | Fold Difference | p* |
Factors whose levels were greater in plasma
| ||||
MDC (pg/mL) | 350 ± 71 | 271 ± 50.2 | 1.30 ± 0.18 | 0.00016 |
IL-16 (pg/mL) | 711 ± 573 | 465 ± 513 | 2.11 ± 1.29 | 0.0033 |
IFN-α (pg/mL) | 11.5 ± 11.2 | 4.0 ± 4.8 | 2.87 ± 1.13 | 0.0095 |
Factors whose levels were greater in recalcified plasma
| ||||
NAP-2 (ng/mL) | 183.8 ± 321.1 | 263.9 ± 305.9 | 1.92 ± 0.59 | 0.00033 |
Factor Levels | ||||
---|---|---|---|---|
Factor | Serum | Recalcified Plasma | Fold Difference | p* |
Factor whose levels were greater in recalcified plasma
| ||||
OPN (pg/mL) | 1.82 ± 1,18 | 3.92 ± 1.38 | 2.6 ± 1.0 | 5.25E-05 |
Factors whose levels were greater in serum
| ||||
MIP-1β (pg/mL) | 98.5 ± 64.0 | 60.2 ± 24.7 | 1.55 ± 0.34 | 0.00012 |
NAP-2 (microg/mL) | 4.79 ± 7.16 | 0.264 ± 0.306 | 31.3 ± 43.9 | 0.00054 |
APO-A1 (microg/mL) | 208.2 ± 38.49 | 173.6 ± 36.09 | 1.21± 0.15 | 0.00083 |
Eotaxin 2 (ng/mL) | 1.98 ± 1.37 | 1.04 ± 0.747 | 1.89 ± 0.68 | 0.00094 |
MCP-2 (pg/mL) | 47.1 ± 11.3 | 27.6 ± 10.5 | 1.92 ± 0.82 | 0.0010 |
TIMP-1 (ng/mL) | 106.3 ± 25.2 | 71.3 ± 13.6 | 1.53 ± 0.44 | 0.0013 |
Lymphotactin (pg/mL) | 125 ± 104 | 76.7 ± 51.0 | 1.73 ± 0.69 | 0.0014 |
MDC (pg/mL) | 340 ± 56 | 271 ± 50 | 1.28 ± 0.24 | 0.0023 |
MMP-2 (ng/mL) | 116.9 ± 20.18 | 105.5 ± 16.9 | 1.11 ± 0.09 | 0.0031 |
L-Selectin (microg/mL) | 2.24 ± 0.35 | 2.00 ± 0.19 | 1.12 ± 0.09 | 0.0032 |
MIP-3α (pg/mL) | 17.1 ± 7.0 | 9.1 ± 3.2 | 2.08 ± 1.34 | 0.0032 |
MCP-3 (pg/mL) | 4.7 ± 3.9 | 0.5 ± 1.5 | 9.4 ± 1.62 | 0.0036 |
PDGF-BB (pg/mL) | 213.8 ± 225.5 | 23.7 ± 22.2 | 9.2 ± 15.2 | 0.0036 |
ITAC (pg/mL) | 78.4 ± 15.8 | 47.9 ± 17.9 | 1.97 ± 1.16 | 0.0043 |
PAI-1 total (ng/mL) | 4.18 ± 3.17 | 1.12 ± 1.03 | 7.99 ± 11.57 | 0.0047 |
APO-B100 (microg/mL) | 535.3 ± 213.6 | 358.9 ± 121.2 | 1.54 ± 0.48 | 0.0074 |
ENA-78 (pg/mL) | 1,449 ± 787 | 718 ± 317 | 2.48 ± 1.89 | 0.0082 |
TNFR1 (pg/mL) | 582 ± 139 | 485 ± 94 | 1.20 ± 0.21 | 0.0094 |
Comparison of factor levels between freshly collected plasma and heat inactivated plasma
Factor Levels | ||||
---|---|---|---|---|
Factor | Plasma | Heat Inactivated Plasma | Fold Difference | p* |
Factors whose levels were greater in heat inactivated plasma
| ||||
MPO (pg/mL) | 359 ± 245 | 2,703 ± 1,171 | 9.29 ± 4.56 | 5.42E-07 |
Eotaxin 2 (pg/mL) | 989 ± 576 | 2,352 ± 1,376 | 2.57 ± 1.04 | 0.00012 |
MCP-1 (pg/mL) | 361 ± 97 | 425 ± 111 | 1.18 ± 0.10 | 0.00014 |
PAI-1 total (pg/mL) | 929 ± 745 | 1,709 ± 183 | 1.62 ± 0.59 | 0.0026 |
TNFR1 (pg/mL) | 422 ± 103 | 499 ± 116 | 1.19 ± 0.20 | 0.0093 |
Factors whose levels were greater in plasma
| ||||
MIP-1α (pg/mL) | 56.4 ± 8.8 | 0.0 ± 0 | NA | 2.76E-14 |
Ang 2 (pg/mL) | 212 ± 95.2 | 0.0 ± 0 | NA | 8.61E-11 |
MDC (pg/mL) | 350 ± 70.6 | 219.7 ± 36.3 | 1.58 ± 0.13 | 2.16E-08 |
IL-6R (ng/mL) | 13.2 ± 4.45 | 0.043 ± 0.072 | 307 ± 563 | 6.67E-08 |
SDF-1β (pg/mL) | 798 ± 137 | 336 ± 95.7 | 2.46 ± 0.47 | 1.86E-07 |
MMP-10 (pg/mL) | 291 ± 183 | 3.3 ± 10.3 | 88.2 ± 10.2 | 2.03E-07 |
VCAM (ng/mL) | 556 ± 133 | 113 ± 43.4 | 5.44 ± 2.23 | 5.36E-07 |
Fibrinogen (microg/mL) | 4,812 ± 1,779 | 0.107 ± 0.300 | 45,029 ± 23,528 | 1.16E-06 |
PAI-1active (pg/mL) | 4,192 ± 4,600 | 67.9 ± 89.0 | 61.7 ± 14.5 | 2.02E-06 |
MMP-2 (ng/mL) | 114 ± 8.4 | 34.1 ± 21.4 | 4.01 ± 1.62 | 7.45E-06 |
ICAM-1 (ng/mL) | 321 ± 37.9 | 201 ± 242 | 1.62 ± 0.3 | 1.33E-05 |
CRP (ng/mL) | 1,749 ± 1,732 | 729 ± 921 | 2.75 ± 0.97 | 1.99E-05 |
MPIF-1 (pg/mL) | 1,618 ± 368 | 483 ± 214 | 4.26 ± 3.18 | 2.12E-05 |
PDGF-BB (pg/mL) | 32.7 ± 19.8 | 7.3 ± 17.7 | 4.48 ± 1.65 | 4.44E-05 |
MIP-3β (pg/mL) | 88.2 ± 22.4 | 43.6 ± 11.7 | 2.11 ± 0.67 | 4.65E-05 |
MIP-3α (pg/mL) | 11.8 ± 6.3 | 2.3 ± 2.1 | 5.13 ± 1.51 | 6.24E-05 |
ITAC (pg/mL) | 51.0 ± 7.3 | 17.6 ± 9.9 | 3.78 ± 1.88 | 6.84E-05 |
MMP-3 (ng/mL) | 13.86 ± 4.42 | 660 ± 610 | 20.99 ± 50.6 | 0.00057 |
RANTES (ng/mL) | 5.77 ± 2.22 | 4.19 ± 1.76 | 1.42 ± 0.32 | 0.00066 |
MIP-1β (pg/mL) | 74.3 ± 58.6 | 53.4 ± 36.0 | 1.38 ± 0.26 | 0.00087 |
HGF (pg/mL) | 532 ± 159 | 353 ± 160 | 1.65 ± 0.48 | 0.00098 |
NAP-2 (ng/mL) | 184 ± 321 | 152 ± 280 | 1.28 ± 0.23 | 0.0011 |
Lymphotactin (pg/mL) | 103.1 ± 95.7 | 64.8 ± 66.6 | 2.11 ± 0.99 | 0.0013 |
G-CSF (pg/mL) | 65.4 ± 46.6 | 24.7 ± 38.2 | 2.65 ± 3.80 | 0.0016 |
IL-16 (pg/mL) | 711 ± 573 | 327 ± 447 | 5.66 ± 6.47 | 0.0018 |
Leptin (ng/mL) | 9.23 ± 12.33 | 1.12 ± 1.24 | 8.25 ± 5.07 | 0.0023 |
TARC (pg/mL) | 41.4 ± 11.8 | 34.5 ± 11.7 | 1.23 ± 0.20 | 0.0025 |
MMP-1 (pg/mL) | 1,170 ± 636 | 248 ± 301 | 4.72 ± 2.13 | 0.0045 |
L-Selectin (microg/mL) | 1.99 ± 0.32 | 1.71 ± 0.20 | 1.16 ± 0.14 | 0.0049 |
TNFR2 (pg/mL) | 434 ± 74 | 295 ± 104 | 1.63 ± 0.68 | 0.0051 |
Eotaxin 2 (pg/mL) | 104 ± 49 | 67.7 ± 40.7 | 1.94 ± 1.26 | 0.0099 |
Comparison of heat inactivated serum, plasma, and recalified plasma with untreated serum, plasma and recalcified plasma
Factor | Heat Inactivated Serum | Heat Inactivated Recalcified Plasma | P* |
---|---|---|---|
ACRP-30 (microg/mL) | 15.9 ± 10.5 | 9.0 ± 5.8 | 0.000209 |
Amphiregulin (pg/mL) | 7 ± 11 | 3 ± 5 | N.S. |
ANG-2 (pg/mL) | 0 ± 0 | 0 ± 0 | N.S. |
Apo A-1 (microg/mL)
|
89.0 ± 16.6
|
70.0 ± 17.3
|
0.000433
|
ApoB-100 (microg/mL)
|
637 ± 147
|
544 ± 98
|
0.00831
|
A-SAA (microg/mL)
|
14.7 ± 4.80
|
11.4 ± 4.12
|
0.00228
|
BDNF (ng/mL) | 7.23 ± 3.04 | 4.17 ± 1.54 | N.S. |
CD14 (pg/mL) | 998 ± 2,439 | 9,922 ± 11,223 | N.S. |
CD40L (pg/mL) | 48 ± 81 | 70 ± 63 | N.S. |
CNTF (pg/mL)
|
0 ± 0
|
0 ± 0
|
N.S.
|
CRP (microg/mL)
|
3.52 ± 0.84
|
2.33 ± 4.71
|
N.S.
|
ENA-78 (pg/mL)
|
637 ± 392
|
343 ± 122
|
N.S.
|
Eotaxin (pg/mL) | 16 ± 26 | 25 ± 14 | N.S. |
Eotaxin2 (ng/mL) | 1.66 ± 1.24 | 3.13 ± 2.33 | 0.000712 |
E-Selectin (ng/mL) | 73.1 ± 16.7 | 70.0 ± 15.0 | N.S. |
Exodus 2 (pg/mL)
|
53 ± 21
|
106 ± 55
|
0.00976
|
FGF Basic (pg/mL)
|
218 ± 175
|
160 ± 219
|
N.S.
|
Fibrinogen (ng/mL)
|
174 ± 44.2
|
217 ± 76.7
|
N.S.
|
G-CSF (pg/mL) | 29 ± 22 | 41 ± 19 | N.S. |
GM-CSF (pg/mL) | 555 ± 267 | 623 ± 311 | N.S. |
GRO-alpha (pg/mL) | 67 ± 61 | 36 ± 12 | N.S. |
HGF (pg/mL)
|
206 ± 124
|
224 ± 43
|
N.S.
|
HGH (pg/mL)
|
164 ± 148
|
159 ± 159
|
N.S.
|
I-309 (pg/mL)
|
27 ± 64
|
21 ± 38
|
N.S.
|
ICAM-1 (ng/mL) | 145 ± 44.3 | 183 ± 48.7 | 0.00518 |
IFN-α (pg/mL) | 1 ± 1.3 | 0.8 ± 1.3 | N.S. |
IFN-γ (pg/mL) | 3 ± 9 | 3 ± 9 | N.S. |
IL-11 (pg/mL)
|
0 ± 0
|
0 ± 0
|
N.S.
|
IL-12p40 (pg/mL)
|
7 ± 15
|
6 ± 10
|
N.S.
|
IL-16 (pg/mL)
|
62 ± 19
|
66 ± 21
|
N.S.
|
IL-1α (pg/mL) | 12 ± 26 | 11 ± 25 | N.S. |
IL-1Ra (pg/mL) | 183 ± 328 | 150 ± 283 | N.S. |
IL-2 (pg/mL) | 22 ± 32 | 21 ± 27 | N.S. |
IL-2R (ng/mL)
|
1.21 ± 0.67
|
1.49 ± 0.78
|
N.S.
|
IL-2Rγ (pg/mL)
|
0 ± 0
|
0 ± 0
|
N.S.
|
IL-6 (pg/mL)
|
7 ± 13
|
7 ± 12
|
N.S.
|
IL-6R (pg/mL) | 30 ± 13 | 40 ± 10 | 0.00451 |
IL-7 (pg/mL) | 5 ± 6 | 0.9 ± 2.6 | N.S. |
IL-8 (pg/mL) | 7 ± 7 | 6 ± 9 | N.S. |
IL-9 (pg/mL)
|
771 ± 1,457
|
608 ± 1,259
|
N.S.
|
IP-10 (pg/mL)
|
128 ± 77
|
141 ± 55
|
N.S.
|
ITAC (pg/mL)
|
8 ± 10
|
8 ± 6
|
N.S.
|
KGF (pg/mL) | 34 ± 17 | 26 ± 12 | N.S. |
LEPTIN (ng/mL) | 2.15 ± 3.04 | 2.56 ± 3.06 | N.S. |
L-Selectin (microg/mL) | 1.16 ± 0.32 | 1.06 ± 0.26 | N.S. |
Lymphotactin (pg/mL)
|
94 ± 107
|
86 ± 94
|
N.S.
|
MCP-1 (pg/mL)
|
456 ± 187
|
514 ± 153
|
N.S.
|
MCP-2 (pg/mL)
|
55 ± 15
|
47 ± 18
|
N.S.
|
MCP-3 (pg/mL) | 0 ± 0 | 0 ± 0 | N.S. |
MCP-4 (pg/mL) | 27 ± 19 | 30 ± 14 | N.S. |
MDC (pg/mL) | 504 ± 127 | 463 ± 92 | N.S. |
MIG (pg/mL)
|
113 ± 61
|
119 ± 59
|
N.S.
|
MIP-1α (pg/mL)
|
60 ± 22
|
43 ± 32
|
N.S.
|
MIP-1β (pg/mL)
|
61 ± 35
|
69 ± 37
|
N.S.
|
MIP-3α (pg/mL) | 6 ± 1 | 7 ± 2 | N.S. |
MIP-3β (pg/mL) | 37 ± 13 | 56 ± 15 | 0.00714 |
MMP-1 (ng/mL) | 3.17 ± 2.19 | 0.68 ± 0.46 | 0.00612 |
MMP-10 (pg/mL)
|
34 ± 45
|
0 ± 0
|
N.S.
|
MMP-13 (pg/mL)
|
60 ± 114
|
0 ± 0
|
N.S.
|
MMP-2 (ng/mL)
|
205 ± 35.7
|
125 ± 31.2
|
1.09 × 10
-05
|
MMP-3 (ng/mL) | 5.58 ± 2.99 | 1.44 ± 0.92 | 5.09 × 10-07 |
MMP-9 (ng/mL) | 48.0 ± 35.6 | 15.4 ± 9.2 | 0.00217 |
MPIF-1 (pg/mL) | 599 ± 184 | 616 ± 199 | N.S. |
MPO (ng/mL)
|
45.8 ± 13.6
|
32.0 ± 6.3
|
0.00206
|
NAP-2 (microg/mL)
|
2.80 ± 2.03
|
0.21 ± 0.20
|
8.47 × 10
-05
|
NT3 (pg/mL)
|
10 ± 9
|
5 ± 8
|
N.S.
|
OPG (pg/mL) | 3 ± 2 | 7 ± 4 | 0.00276 |
OPN (ng/mL) | 2.13 ± 1.50 | 2.91 ± 2.68 | N.S. |
PAI-1 Active (pg/mL) | 211 ± 179 | 97 ± 93 | N.S. |
PAI-1 Total (ng/mL)
|
4.33 ± 2.72
|
1.67 ± 1.54
|
0.00585
|
PDGF-BB (pg/mL)
|
165 ± 171
|
85 ± 198
|
N.S.
|
RANTES (ng/mL)
|
10.8 ± 12.2
|
3.9 ± 1.5
|
N.S.
|
SDF-1β (pg/mL) | 173 ± 156 | 237 ± 172 | N.S. |
TARC (pg/mL) | 74 ± 41 | 39 ± 10 | N.S. |
TIMP-1 (ng/mL) | 121 ± 56.4 | 82.3 ± 17.1 | N.S. |
TIMP-2 (ng/mL)
|
109 ± 25.8
|
94.0 ± 16.2
|
N.S.
|
TNF-α (pg/mL)
|
46 ± 35
|
48 ± 38
|
N.S.
|
TNF-RI (pg/mL)
|
433 ± 115
|
413 ± 111
|
N.S.
|
TNF-R2 (pg/mL) | 150 ± 46 | 584 ± 136 | 6.63 × 10-07 |
VCAM-1 (ng/mL) | 46.5 ± 13.6 | 69.1 ± 12.0 | 0.000540 |